Background Image
Table of Contents Table of Contents
Flipping Book - TVD Next Page
Information
Show Menu
Flipping Book - TVD Next Page

 


L01 Morphologic Imaging Techniques - Delorme 		8
L02 Functional & Biological Imaging Techniques - Delorme 		19
L03 ICRY 50, ICRU 62 and Beyond - Madani, Kunze-Busch and Remeijer 		31
GTV, CTV and PTV(ICRU 62 + 83 and beyond) Neil Burnet 		31
Slide Number 2 		32
GTV, CTV and PTV 		33
Learning Objectives 		34
The history of radiotherapy 		35
Slide Number 6 		36
Imaging - technology advance 		37
Target volumes 		38
Target volumes 		39
Target volumes 		40
Target volumes 		41
Target volumes 		42
Target volumes 		43
Target volumes - GTV 		44
Target volumes - GTV 		45
Target volumes - GTV 		46
Target volumes - GTV 		47
Slide Number 18 		48
Slide Number 19 		49
Slide Number 20 		50
Slide Number 21 		51
Slide Number 22 		52
Target volumes - GTV 		53
Target volumes - GTV 		54
Target volumes - GTV 		55
Target volumes - GTV 		56
Improving concordance 		57
Improving concordance 		58
Improving concordance 		59
Improving concordance 		60
Quality of RT affects outcome 		61
Quality of RT affects outcome 		62
Target volumes - CTV 		63
Target volumes - CTV 		64
Target volumes - CTV 		65
Target volumes - CTV 		66
Target volumes - CTV 		67
Slide Number 38 		68
Slide Number 39 		69
Target volumes - CTV 		70
Target volumes - PTV 		71
Target volumes - PTV 		72
Target volumes - PTV 		73
Target volumes - PTV 		74
Target volumes - PTV 		75
Target volumes - PTV 		76
Target volumes - PTV 		77
Target volumes – PTV 		78
Target volumes – PTV 		79
Target volumes 		80
Target volumes – PTV 		81
Target volumes 		82
Target volumes – PTV 		83
Target volumes – PTV 		84
Target volumes – PTV - Adaptation 		85
Slide Number 56 		86
Target volumes – OARs + PRVs ( and RVR) 		87
Slide Number 58 		88
Target volumes – OARs 		89
OARs 		90
OARs 		91
Target volumes - OARs 		92
Target volumes – OARs 		93
Target volumes – OARs 		94
Target volumes – OARs + PRVs 		95
Target volumes – PRV 		96
 Tissue architecture 		97
Target volumes – PRV 		98
Target volumes – PRV 		99
Target volumes – PRV 		100
PRV 		101
Slide Number 72 		102
Slide Number 73 		103
Slide Number 74 		104
Slide Number 75 		105
Slide Number 76 		106
Target volumes – PTV + PRV 		107
Target volumes – overlaps 		108
Target volumes – overlaps 		109
Slide Number 80 		110
Slide Number 81 		111
Slide Number 82 		112
Target volumes 		113
Slide Number 84 		114
Slide Number 85 		115
Target volumes – PTV / PRV 		116
Target volumes – overlaps 		117
Target volumes – overlaps 		118
Slide Number 89 		119
Take home messages 		120
Take home messages 		121
Radiation oncology - a team effort 		122
L04 Image Handling - Kunze-Busch 		123
Slide Number 1 		123
Slide Number 2 		124
Slide Number 3 		125
Overview 		126
Image data in RT chain 		127
Treatment preparation – diagnostic scan 		128
Treatment preparation – diagnostic scan 		129
Treatment preparation – planning CT 		130
Treatment preparation – planning CT 		131
Treatment preparation – planning (PET/)CT 		132
Treatment preparation – delineation 		133
Dealing with tumor motion 		134
Slide Number 13 		135
Slide Number 14 		136
Treatment preparation – display 		137
Treatment preparation – registration 		138
Image data in RT chain 		139
Treatment delivery – ImageGuidedRT 		140
Treatment delivery – IGRT 		141
Treatment delivery – IGRT 		142
Treatment delivery – IGRT 		143
Next IGRT generation: MR-guided RT 		144
Slide Number 23 		145
Image data in RT chain 		146
Slide Number 25 		147
Slide Number 26 		148
Take home messages 		149
Slide Number 28 		150
L05 Inter-Obser Variation in Radiotherapy Delineation - Remeijer 		151
Slide Number 1 		151
Inter-observer variation in target volume delineation 		152
Slide Number 3 		153
What influences delineation uncertainty? 		154
Lack of coffee….. 		155
… or too much coffee 		156
Level/window 		157
Modalities 		158
Resolution 		159
MRI artifacts can cause invisible geometrical errors! 		160
Registration 		161
Why is this so important? 		162
How to analyze? 		163
How to analyze: Volumes? 		164
How to analyze: Volumes? 		165
How to analyze? 		166
How to analyze? 		167
Distance maps 		168
Systematic modality difference (axial MRI - CT) 		169
Overall observer variation in CT (SD) 		170
What next? 		171
Slide Number 22 		172
Slide Number 23 		173
Slide Number 24 		174
Slide Number 25 		175
Slide Number 26 		176
Slide Number 27 		177
Slide Number 28 		178
Slide Number 29 		179
Slide Number 30 		180
“Big Brother” 		181
Slide Number 32 		182
Slide Number 33 		183
Slide Number 34 		184
Matched MRI – CT 		185
Slide Number 36 		186
Conclusions 		187
Slide Number 38 		188
Slide Number 39 		189
L06 From Uncertainties to Margins - Remeijer 		190
From uncertainties to margins 		190
Introduction 		191
Some examples 		192
Slide Number 4 		193
The radiotherapy chain 		194
Geometrical uncertainties 		195
Geometrical uncertainties 		196
Effect of geometrical errors 		197
Geometrical uncertainties 		198
Many varieties 		199
But also different sources! 		200
Slide Number 12 		201
Prostate 		202
Bladder 		203
Slide Number 15 		204
Determining the uncertainties 		205
Determining the uncertainties 		206
Determining the uncertainties 		207
Slide Number 19 		208
How do we determine the margin? 		209
Effect of geometrical errors 		210
Margins for random errors 		211
Margins for random errors 		212
Slide Number 24 		213
Margins for systematic errors 		214
Margins for systematic errors 		215
PTV for systematic translations 		216
Margins for systematic translations 		217
Slide Number 29 		218
Margin recipe 		219
Keeping things in perspective 		220
GTV versus CTV underdosage 		221
GTV versus CTV underdosage 		222
Keeping things in perspective 		223
Conclusions 		224
Slide Number 36 		225
Slide Number 37 		226
Slide Number 38 		227
L07A Image Registration - Kunze-Busch 		228
Slide Number 1 		228
Slide Number 2 		229
Overview 		230
Slide Number 4 		231
Slide Number 5 		232
Slide Number 6 		233
1. Geometrical transformation T 		234
1. Geometrical transformation T 		235
1. Geometrical transformation T 		236
1. Geometrical transformation T 		237
2. Similarity measure 		238
2. Similarity measure 		239
Slide Number 13 		240
Slide Number 14 		241
Slide Number 15 		242
3. Optimizer/optimization algorithm 		243
Image registration in the RT chain 		244
Image registration in the RT chain 		245
Treatment preparation 		246
Slide Number 20 		247
different scanning position 		248
motion 		249
scans at different points in time 		250
Image registration in the RT chain 		251
Slide Number 25 		252
CT – CBCT: Bone registration 		253
CT – CBCT: Bone registration 		254
grey value registration 		255
Slide Number 29 		256
Slide Number 30 		257
Image registration in the RT chain 		258
Quantification of organ motion 		259
Impact on margins? 		260
Slide Number 34 		261
Slide Number 35 		262
Slide Number 36 		263
L07B Image Registration - Kunze-Busch 		264
Slide Number 1 		264
Slide Number 2 		265
Available software programs 		266
Slide Number 4 		267
Slide Number 5 		268
Slide Number 6 		269
Slide Number 7 		270
Clinical implementation 		271
Physical or digital QA 		272
Slide Number 10 		273
Task group 132 		274
Slide Number 12 		275
L8 Anatomy and Lymph Node Drainage in the Mediastinum - Troost 		276
Slide Number 1 		276
Slide Number 2 		277
Slide Number 3 		278
Slide Number 4 		279
Slide Number 5 		280
Slide Number 6 		281
Slide Number 7 		282
Slide Number 8 		283
Slide Number 9 		284
Slide Number 10 		285
Slide Number 11 		286
Slide Number 12 		287
Slide Number 13 		288
Slide Number 14 		289
Slide Number 15 		290
Slide Number 16 		291
Slide Number 17 		292
Slide Number 18 		293
Slide Number 19 		294
Slide Number 20 		295
Slide Number 21 		296
Slide Number 22 		297
Slide Number 23 		298
Slide Number 24 		299
Slide Number 25 		300
Slide Number 26 		301
L09 Anatomy & Lymph Node Drainage for Breast Cancer - Delorme 		302
L10 GTV and CTV for Breast Cancer - Arenas 		315
Slide Number 1 		315
Slide Number 2 		316
Slide Number 3 		317
Slide Number 4 		318
Slide Number 5 		319
Slide Number 6 		320
Slide Number 7 		321
Slide Number 8 		322
Slide Number 9 		323
Slide Number 10 		324
Slide Number 11 		325
Slide Number 12 		326
Slide Number 13 		327
Slide Number 14 		328
Slide Number 15 		329
Slide Number 16 		330
Slide Number 17 		331
Slide Number 18 		332
Slide Number 19 		333
Slide Number 20 		334
Slide Number 21 		335
Slide Number 22 		336
Slide Number 23 		337
Slide Number 24 		338
Slide Number 25 		339
Slide Number 26 		340
Slide Number 27 		341
Slide Number 28 		342
Slide Number 29 		343
Slide Number 30 		344
Slide Number 31 		345
Slide Number 32 		346
Slide Number 33 		347
Slide Number 34 		348
Slide Number 35 		349
Slide Number 36 		350
Slide Number 37 		351
Slide Number 38 		352
Slide Number 39 		353
Slide Number 40 		354
Slide Number 41 		355
Slide Number 42 		356
Slide Number 43 		357
Slide Number 44 		358
Slide Number 45 		359
Slide Number 46 		360
Slide Number 47 		361
Slide Number 48 		362
Slide Number 49 		363
Slide Number 50 		364
Slide Number 51 		365
Slide Number 52 		366
Slide Number 53 		367
Slide Number 54 		368
Slide Number 55 		369
Slide Number 56 		370
Slide Number 57 		371
Slide Number 58 		372
Slide Number 59 		373
Slide Number 60 		374
Slide Number 61 		375
Slide Number 62 		376
Slide Number 63 		377
Slide Number 64 		378
Slide Number 65 		379
Slide Number 66 		380
Slide Number 67 		381
Slide Number 68 		382
Slide Number 69 		383
Slide Number 70 		384
Slide Number 71 		385
Slide Number 72 		386
Slide Number 73 		387
Slide Number 74 		388
Slide Number 75 		389
Slide Number 76 		390
Slide Number 77 		391
Slide Number 78 		392
Slide Number 79 		393
Slide Number 80 		394
Slide Number 81 		395
Slide Number 82 		396
Slide Number 83 		397
Slide Number 84 		398
Slide Number 85 		399
Slide Number 86 		400
Slide Number 87 		401
Slide Number 88 		402
Slide Number 89 		403
Slide Number 90 		404
Slide Number 91 		405
Slide Number 92 		406
Slide Number 93 		407
Slide Number 94 		408
Slide Number 95 		409
Slide Number 96 		410
Slide Number 97 		411
Slide Number 98 		412
Slide Number 99 		413
Slide Number 100 		414
Slide Number 101 		415
Slide Number 102 		416
Slide Number 103 		417
Slide Number 104 		418
Slide Number 105 		419
L11 Anatomy & Lymph Node Drainage for Lung Cancer - Delorme 		420
L12 GTV and CTV for Lunch Cancer - Troost 		431
Slide Number 1 		431
Slide Number 2 		432
Slide Number 3 		433
Slide Number 4 		434
Slide Number 5 		435
Slide Number 6 		436
Slide Number 7 		437
Slide Number 8 		438
Slide Number 9 		439
Slide Number 10 		440
Slide Number 11 		441
Slide Number 12 		442
Slide Number 13 		443
Slide Number 14 		444
Slide Number 15 		445
Slide Number 16 		446
Slide Number 17 		447
Slide Number 18 		448
Slide Number 19 		449
Slide Number 20 		450
Slide Number 21 		451
Slide Number 22 		452
Slide Number 23 		453
Slide Number 24 		454
Slide Number 25 		455
Slide Number 26 		456
Slide Number 27 		457
Slide Number 28 		458
Slide Number 29 		459
Slide Number 30 		460
Imaging vs pathology 		461
Slide Number 32 		462
Slide Number 33 		463
Slide Number 34 		464
Slide Number 35 		465
Slide Number 36 		466
Slide Number 37 		467
Slide Number 43 		468
Slide Number 44 		469
Slide Number 45 		470
Slide Number 46 		471
Slide Number 47 		472
Slide Number 48 		473
Slide Number 49 		474
Slide Number 50 		475
Slide Number 51 		476
Slide Number 52 		477
Slide Number 53 		478
Slide Number 54 		479
L15 Anatomy & Lymph Node Drainage for H&N Cancer - Carey 		480
L16 CTV of the Elective Neck - Madani 		517
Slide Number 1 		517
Slide Number 2 		518
Slide Number 3 		519
Slide Number 4 		520
Slide Number 5 		521
Slide Number 6 		522
Slide Number 7 		523
Slide Number 8 		524
Slide Number 9 		525
Slide Number 10 		526
Slide Number 11 		527
Slide Number 12 		528
Slide Number 13 		529
Slide Number 14 		530
Slide Number 15 		531
Slide Number 16 		532
Slide Number 17 		533
Slide Number 18 		534
Slide Number 19 		535
Slide Number 20 		536
Slide Number 21 		537
Slide Number 22 		538
Slide Number 23 		539
Slide Number 24 		540
Slide Number 25 		541
Slide Number 26 		542
Slide Number 27 		543
Slide Number 28 		544
Slide Number 29 		545
Slide Number 30 		546
Slide Number 31 		547
Slide Number 32 		548
Slide Number 33 		549
Slide Number 34 		550
Slide Number 35 		551
Slide Number 36 		552
Slide Number 37 		553
Slide Number 38 		554
Slide Number 39 		555
Slide Number 40 		556
Slide Number 41 		557
Slide Number 42 		558
Slide Number 43 		559
Slide Number 44 		560
Slide Number 45 		561
Slide Number 46 		562
Slide Number 47 		563
Slide Number 48 		564
Slide Number 49 		565
Slide Number 50 		566
Slide Number 51 		567
Slide Number 52 		568
Slide Number 53 		569
Slide Number 54 		570
Slide Number 55 		571
Slide Number 56 		572
Slide Number 57 		573
L17 GTV and CTV for H&N Cancer - Madani 		574
Slide Number 1 		574
Slide Number 2 		575
Slide Number 3 		576
Slide Number 4 		577
Slide Number 5 		578
Slide Number 6 		579
Slide Number 7 		580
Slide Number 8 		581
Slide Number 9 		582
Slide Number 10 		583
Slide Number 11 		584
Slide Number 12 		585
Slide Number 13 		586
Slide Number 14 		587
Slide Number 15 		588
Slide Number 16 		589
Slide Number 17 		590
Slide Number 18 		591
Slide Number 19 		592
Slide Number 20 		593
Slide Number 21 		594
Slide Number 22 		595
Slide Number 23 		596
Slide Number 24 		597
Slide Number 25 		598
Slide Number 26 		599
Slide Number 27 		600
Slide Number 28 		601
Slide Number 29 		602
Slide Number 30 		603
Slide Number 31 		604
Slide Number 32 		605
Slide Number 33 		606
Slide Number 34 		607
Slide Number 35 		608
Slide Number 36 		609
Slide Number 37 		610
Slide Number 38 		611
Slide Number 39 		612
Slide Number 40 		613
Slide Number 41 		614
L19 Anatomy for CNS Tumours - Delorme 		615
L20 GTV and CTV for CNS Tumors - Jefferies 		624
CTV for gliomas Neil Burnet & Sarah Jefferies 		624
Slide Number 2 		625
CNS Tumours 		626
Learning Objectives 		627
High Grade Glioma (HGG) 		628
HGG 		629
Tumour Spread 		630
Tumour Spread 		631
Tumour Spread 		632
Tumour Spread 		633
Tumour spread 		634
Slide Number 12 		635
Tumour spread 		636
Slide Number 14 		637
Tumour spread 		638
Inter-thalamic adhesion 		639
Inter-thalamic adhesion 		640
Tumour Spread 		641
HGG - CTV 		642
Essentials 		643
HGG - GTV 		644
GBM - presentation 		645
GBM early post-op imaging 		646
Slide Number 24 		647
Slide Number 25 		648
Slide Number 26 		649
HGG - GTV 		650
HGG - GTV 		651
HGG - GTV 		652
Slide Number 30 		653
HGG Invasion 		654
GTV – True extent of tumour 		655
HGG – GTV definitions 		656
Surgical Cavity 		657
Slide Number 35 		658
HGG – GTV / CTV 		659
HGG – GTV / CTV 		660
Slide Number 38 		661
Slide Number 39 		662
Slide Number 40 		663
Slide Number 41 		664
From GTV to CTV 		665
Slide Number 43 		666
Slide Number 44 		667
HGG - CTV 		668
HGG - CTV 		669
Oedema 		670
Slide Number 48 		671
HGG - CTV 		672
Slide Number 50 		673
Slide Number 51 		674
Slide Number 52 		675
Oedema – include or not? 		676
Oedema – include or not? 		677
Oedema – include or not? 		678
GTV - T1+Gd or oedema 		679
HGG - CTV 		680
Slide Number 58 		681
Slide Number 59 		682
Slide Number 60 		683
High grade glioma - PTV 		684
Slide Number 62 		685
Slide Number 63 		686
High grade glioma 		687
Slide Number 65 		688
CNS case 		689
Slide Number 67 		690
Slide Number 68 		691
Slide Number 69 		692
GBM - IMRT plan DVHs 		693
Slide Number 71 		694
Low Grade Glioma (LGG) 		695
Low grade glioma 		696
Low grade glioma 		697
Slide Number 75 		698
Slide Number 76 		699
Slide Number 77 		700
Low grade glioma 		701
LGG - GTV 		702
GTV – True extent of tumour 		703
Slide Number 81 		704
Slide Number 82 		705
Low grade glioma - CTV 		706
LGG 		707
LGG 		708
LGG 		709
LGG 		710
LGG 		711
LGG – CTV Suggested margins 		712
Summary 		713
LGG cases 		714
Slide Number 92 		715
Slide Number 93 		716
Slide Number 94 		717
Slide Number 95 		718
Normal tissue tolerance 		719
New Guidelines for OAR 		720
Normal tissue tolerance 		721
Optic nerve tolerance & risk 		722
Optic nerve tolerance & risk 		723
Chemo + RT for GBM 		724
Optic nerve tolerance & risk 		725
Optic nerve tolerance & risk 		726
Optic nerve tolerance & risk 		727
Optic nerve tolerance & risk 		728
Optic nerve tolerance & risk 		729
Thank you ! 		730
L22 Anatomy & Lymph Node Drainage for Upper GI Cancer - Carey 		731
L23 GTV and CTV for Oesophageal Cancer - Gambacorta 		763
GTV and CTV delineation for Esophageal cancer- Organ at risk delineation 		763
Esophageal cancer 		764
Esophageal cancer 		765
Treatment approaches 		766
Treatment approaches 		767
Treatment approaches 		768
Treatment indications 		769
Esophageal cancer 		770
Sites of recurrence 		771
Sites of recurrence 		772
Esophageal cancer 		773
Esophageal cancer 		774
Target volume delineation 		775
GTV definition 		776
GTV definition 		777
GTV-T definition:CT Scan 		778
CT Scan for GTV-T definition: infiltration of adjacent organs 		779
CT Scan for GTV-T definition: infiltration of adjacent organs 		780
CT Scan for GTV-T definition: infiltration of adjacent organs 		781
GTV-N definition:CT Scan 		782
CT Scan for GTV-N definition: lymphnodal metastases 		783
How to improve GTV definition 		784
GTV delineation in CT & PET 		785
GTV delineation in CT & PET 		786
GTV delineation in CT & PET 		787
Slide Number 26 		788
Slide Number 27 		789
Slide Number 28 		790
Slide Number 29 		791
PET for GTV definition: summary 		792
GTV delineation: summary 		793
Esophageal cancer 		794
CTV definition in clinical trials 		795
CTV-T 		796
CTV-T Length along esophagus 		797
CTV Length along esophagus 		798
CTV Length along esophagus 		799
CTV Length along esophagus 		800
CTV longitudinal margins 		801
CTV radial margins 		802
CTVs definition 		803
Esophageal cancer 		804
The importance of lymphnodal spread 		805
The importance of lymphnodal spread 		806
The importance of lymphnodal spread 		807
The importance of lymphnodal spread 		808
The importance of lymphnodal spread 		809
The importance of lymphnodal spread 		810
The importance of lymphnodal spread 		811
The importance of lymphnodal spread 		812
The importance of lymphnodal spread 		813
The importance of lymphnodal spread 		814
Lymphnodal spread according to T location 		815
Lymphnodes classification 		816
Cervical level 		817
Slide Number 56 		818
Cervical CT axial anatomy 		819
Thoracic level 		820
Thoracic level: axial anatomy 		821
Slide Number 60 		822
Thoracic level: axial anatomy 		823
Thoracic CT anatomy 		824
Abdominal level 		825
Slide Number 64 		826
CTV-elective definition 		827
CTV-elective: cervical 		828
CTV-elective: upper thoracic 		829
CTV-elective: middle thoracic 		830
CTV-elective: lower thoracic 		831
Take home 		832
Gastro-esophageal tumor 		833
GEJ: GTV and CTV (T, N) 		834
Slide Number 73 		835
Slide Number 74 		836
Slide Number 75 		837
Slide Number 76 		838
GEJ: CTV elective; Type I 		839
GEJ: CTV elective; Type II 		840
GEJ: CTV elective; Type III 		841
OARs organization and delineation 		842
OARs constraints and delineation 		843
OARs delineation variability 		844
OARs not preventable toxicities 		845
Slide Number 84 		846
L24 GTV and CTV for Gastric Cancer - Gambacorta 		847
GTV and CTV for gastric cancer – Delineation of Organ at risk 		847
Target Volume Definition 		848
Evidences:Surgical treatment 		849
Slide Number 4 		850
Evidences:Sites of Recurrence 		851
Evidences:Sites of Recurrence 		852
Evidences:INT-0116 Overall Survival 		853
Evidences:INT-0116 Surgical Quality Review 		854
Treatment Guidelines 		855
Evidences:Why preoperative treatments? 		856
Evidences:Why preoperative treatments? 		857
Slide Number 12 		858
Evidences: compliance, RT targeting 		859
Evidences: compliance, RT targeting 		860
Target Volume Definition 		861
Areas at risk 		862
Areas at risk 		863
Areas at risk post-op: Tumor bed/remnant 		864
Areas at Risk post-op: Tumor bed 		865
Areas at Risk post-op: Tumor bed 		866
Areas at risk post-op 		867
Areas at Risk post-op: Anastomosis & Stump 		868
Area at Risk post-op: Anastomosis 		869
Area at Risk: Anastomosis & Stump 		870
Area at Risk post-op: Duodenal Stump 		871
Area at Risk post-op: Anastomosis & Stump 		872
Target volume definition: pre-op 		873
Target volume definition: pre-op 		874
Target volume definition: pre-op 		875
Target volume definition: pre-op 		876
Area at Risk pre/post-op: Elective Nodes 		877
Area at Risk pre/post-op: Elective Nodes 		878
Areas at Risk: Elective Nodes 		879
Gastric level (1 – 6) 		880
Gastric level (1 – 6) 		881
Slide Number 36 		882
Slide Number 37 		883
Slide Number 38 		884
Slide Number 39 		885
Slide Number 40 		886
Slide Number 41 		887
Pancreatic level (7 – 18) 		888
Pancreatic level (7 – 18) 		889
Pancreatic level (7 – 18) 		890
Slide Number 45 		891
Slide Number 46 		892
Slide Number 47 		893
Slide Number 48 		894
Slide Number 49 		895
Vascular level (16-19) 		896
Vascular level (16-19) 		897
Vascular level (16-19) 		898
Vascular level (16-19): topography 		899
Vascular level (16-19): axial anatomy 		900
Vascular level (16-19): axial anatomy 		901
Vascular level (16-19): axial anatomy 		902
Vascular level (16-19): axial anatomy 		903
Slide Number 58 		904
Slide Number 59 		905
Slide Number 60 		906
Slide Number 61 		907
Slide Number 62 		908
Target Volume Delineation 		909
Slide Number 64 		910
Slide Number 65 		911
Slide Number 66 		912
Slide Number 67 		913
Slide Number 68 		914
Slide Number 69 		915
Slide Number 70 		916
Slide Number 71 		917
Slide Number 72 		918
Slide Number 73 		919
Slide Number 74 		920
Slide Number 75 		921
Slide Number 76 		922
Slide Number 77 		923
Slide Number 78 		924
Slide Number 79 		925
Slide Number 80 		926
Slide Number 81 		927
Slide Number 82 		928
Slide Number 83 		929
Slide Number 84 		930
Slide Number 85 		931
Slide Number 86 		932
Slide Number 87 		933
Slide Number 88 		934
Slide Number 89 		935
Slide Number 90 		936
Organ At Risk 		937
INT-0116: compliance to chemoradiation 		938
INT-0116: Side Effects(Grade 3 - 4 WHO) 		939
OARs constraints and delineation 		940
OARs constraints and delineation 		941
Conclusions: Target Volume Definition 		942
Slide Number 97 		943
L25 Anatomy & Lymph Node Drainage for Rectal and Anal Cancer - Carey 		944
L26 GTV and CTV for Rectal Cancer - Gambacorta 		980
GTV and CTV for Rectal Cancer 		980
Slide Number 2 		981
Slide Number 3 		982
CTV: what to include 		983
CTV in rectal cancer 		984
TME clinical target 		985
Slide Number 7 		986
Slide Number 8 		987
Slide Number 9 		988
Slide Number 10 		989
Slide Number 11 		990
Slide Number 12 		991
Slide Number 13 		992
Slide Number 14 		993
Slide Number 15 		994
Slide Number 16 		995
Slide Number 17 		996
Slide Number 18 		997
Slide Number 19 		998
Slide Number 20 		999
Slide Number 21 		1000
Slide Number 22 		1001
Slide Number 23 		1002
Slide Number 24 		1003
Slide Number 25 		1004
Slide Number 26 		1005
Slide Number 27 		1006
Slide Number 28 		1007
Slide Number 29 		1008
Slide Number 30 		1009
Slide Number 31 		1010
Slide Number 32 		1011
Slide Number 33 		1012
Slide Number 34 		1013
Slide Number 35 		1014
Slide Number 36 		1015
Slide Number 37 		1016
Slide Number 38 		1017
Delineation guidelines 		1018
Slide Number 40 		1019
Delineation guidelines 		1020
Mesorectum: delineation guidelines 		1021
Mesorectum: delineation guidelines 		1022
Presacral: delineation guidelines 		1023
Lateral spaces: delineation guidelines 		1024
Lateral spaces 		1025
Lateral spaces 		1026
Slide Number 48 		1027
Slide Number 49 		1028
Delineation guidelines 		1029
Delineation guidelines 		1030
CTV modulation 		1031
Slide Number 53 		1032
Slide Number 54 		1033
Slide Number 55 		1034
Slide Number 56 		1035
Slide Number 57 		1036
Slide Number 58 		1037
Slide Number 59 		1038
Inferior pelvic subsite(sphincter complex and ischiorectal fossae) 		1039
Inferior pelvic subsite 		1040
Inferior pelvic subsite 		1041
CTV modulation 		1042
Inguinal nodes 		1043
PTV definition 		1044
Slide Number 66 		1045
Slide Number 67 		1046
L27 GTV and CTV for Anal Cancer - Gambacorta 		1047
GTV and CTV delineation for Anal CancerDelineation of Organ at Risk in Ano-Rectal cancer 		1047
Slide Number 2 		1048
Slide Number 3 		1049
Slide Number 4 		1050
Slide Number 5 		1051
Slide Number 6 		1052
Slide Number 7 		1053
Slide Number 8 		1054
Slide Number 9 		1055
Slide Number 10 		1056
Slide Number 11 		1057
Slide Number 12 		1058
Slide Number 13 		1059
Slide Number 14 		1060
Slide Number 15 		1061
Slide Number 16 		1062
Slide Number 17 		1063
Slide Number 19 		1064
Slide Number 20 		1065
Slide Number 21 		1066
Slide Number 22 		1067
Slide Number 23 		1068
Slide Number 24 		1069
Slide Number 25 		1070
Slide Number 26 		1071
Slide Number 27 		1072
Slide Number 28 		1073
Slide Number 29 		1074
Slide Number 30 		1075
Slide Number 31 		1076
Slide Number 32 		1077
Slide Number 33 		1078
Slide Number 34 		1079
Slide Number 35 		1080
Slide Number 36 		1081
Slide Number 37 		1082
Slide Number 38 		1083
Slide Number 39 		1084
Slide Number 41 		1085
OARs in ano-rectal 		1086
Anal cancer delineation 		1087
Slide Number 46 		1088
Slide Number 47 		1089
Slide Number 48 		1090
Slide Number 49 		1091
Slide Number 50 		1092
Slide Number 51 		1093
Slide Number 52 		1094
Slide Number 53 		1095
Slide Number 54 		1096
Slide Number 55 		1097
Sexual function (male*) 		1098
Sexual function (male*) 		1099
Slide Number 58 		1100
Slide Number 59 		1101
Ano-Rectum OAR 		1102
L28 Anatomy & Lymph Node Drainage for Gyneacological Cancer - Carey 		1103
L29 GTV and CTV for Cervical Cancer - De Meerleer 		1140
Slide Number 1 		1140
Slide Number 2 		1141
Slide Number 3 		1142
Slide Number 4 		1143
Slide Number 5 		1144
Slide Number 6 		1145
Slide Number 7 		1146
Slide Number 8 		1147
Slide Number 9 		1148
Slide Number 10 		1149
Slide Number 11 		1150
Slide Number 12 		1151
Slide Number 13 		1152
Slide Number 14 		1153
Slide Number 15 		1154
Slide Number 16 		1155
Slide Number 17 		1156
Slide Number 18 		1157
Major issue: healthy tissue 		1158
Major issue: healthy tissue 		1159
Major issue: healthy tissue 		1160
Major issue: healthy tissue 		1161
Slide Number 23 		1162
Slide Number 24 		1163
Slide Number 25 		1164
Slide Number 26 		1165
Slide Number 27 		1166
Slide Number 28 		1167
Slide Number 29 		1168
Slide Number 30 		1169
Slide Number 31 		1170
Slide Number 32 		1171
Slide Number 33 		1172
Slide Number 34 		1173
Slide Number 35 		1174
Slide Number 36 		1175
Slide Number 37 		1176
Slide Number 38 		1177
Slide Number 39 		1178
L30 GTV and CTV in the Postoperative Gynaecological Setting - De Meerleer 		1179
Slide Number 1 		1179
Slide Number 2 		1180
Slide Number 3 		1181
Slide Number 4 		1182
Slide Number 5 		1183
Slide Number 6 		1184
Slide Number 7 		1185
Slide Number 8 		1186
Slide Number 9 		1187
Slide Number 10 		1188
Slide Number 11 		1189
Slide Number 12 		1190
Slide Number 13 		1191
Slide Number 14 		1192
Slide Number 15 		1193
Slide Number 16 		1194
Slide Number 17 		1195
Slide Number 18 		1196
Slide Number 19 		1197
Slide Number 20 		1198
Slide Number 21 		1199
Slide Number 22 		1200
Slide Number 23 		1201
Slide Number 24 		1202
Slide Number 25 		1203
Slide Number 26 		1204
Slide Number 27 		1205
Slide Number 28 		1206
Slide Number 29 		1207
Slide Number 30 		1208
Slide Number 31 		1209
Slide Number 32 		1210
L31 Anatomy & Lymph Node Drainage for Prostate Cancer - Delorme 		1211
L32 GTV and CTV for Prostate Cancer - De Meerleer 		1222
Slide Number 1 		1222
Slide Number 2 		1223
Slide Number 3 		1224
Slide Number 4 		1225
MR in radiotherapy: Debois IJROBP 1999; 45: 857-865. 		1226
MR in radiotherapy: Debois IJROBP 1999; 45: 857-865. 		1227
MR in radiotherapy: Debois IJROBP 1999; 45: 857-865. 		1228
Slide Number 8 		1229
MRI 		1230
MRI 		1231
Slide Number 11 		1232
Slide Number 12 		1233
Slide Number 13 		1234
Biochemical failure (Multivariate Analysis) 		1235
Biochemical failure (Multivariate Analysis) 		1236
Slide Number 16 		1237
Slide Number 17 		1238
Slide Number 18 		1239
Slide Number 19 		1240
Slide Number 20 		1241
Slide Number 21 		1242
Slide Number 22 		1243
Slide Number 23 		1244
Slide Number 24 		1245
Slide Number 25 		1246
Slide Number 26 		1247
Slide Number 27 		1248
Slide Number 28 		1249
Slide Number 29 		1250
Slide Number 30 		1251
Slide Number 31 		1252
Slide Number 32 		1253
Slide Number 33 		1254
Slide Number 34 		1255
Slide Number 35 		1256
Biochemical control ≈ IPL for high risk 		1257
Elective nodal irradiation? 		1258
Slide Number 38 		1259
Slide Number 39 		1260
Slide Number 40 		1261
Slide Number 41 		1262
Slide Number 42 		1263
Slide Number 43 		1264
Slide Number 44 		1265
Slide Number 45 		1266
Slide Number 46 		1267
Slide Number 47 		1268
What if pN+ disease? 		1269
Slide Number 49 		1270
Slide Number 50 		1271
Slide Number 51 		1272
Slide Number 52 		1273
Slide Number 53 		1274
Slide Number 54 		1275
Slide Number 55 		1276
Slide Number 56 		1277
Slide Number 57 		1278
Slide Number 58 		1279
Slide Number 59 		1280
Slide Number 60 		1281
L33 GTV and CTV in the Postoperative Prostate Cancer Setting - De Meerleer 		1282
Postoperative setting? 		1282
Slide Number 2 		1283
Slide Number 3 		1284
Slide Number 4 		1285
Slide Number 5 		1286
Slide Number 6 		1287
Slide Number 7 		1288
Slide Number 8 		1289
Slide Number 9 		1290
Slide Number 10 		1291
Slide Number 11 		1292
Slide Number 12 		1293
Slide Number 13 		1294
Slide Number 14 		1295
Slide Number 15 		1296
Slide Number 16 		1297
Slide Number 17 		1298
Slide Number 18 		1299
Slide Number 19 		1300
Slide Number 20 		1301
Slide Number 21 		1302
Slide Number 22 		1303
Slide Number 23 		1304
Slide Number 24 		1305
Slide Number 25 		1306
Slide Number 26 		1307
Slide Number 27 		1308
Slide Number 28 		1309
Slide Number 29 		1310
Slide Number 30 		1311
 FlippingBook